Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome

Begenik H., Soyoral Y. U., Erkoc R., Emre H., TAŞKIN A., Tasdemir M., ...Daha Fazla

REDOX REPORT, cilt.18, sa.3, ss.107-112, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 3
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1179/1351000213y.0000000048
  • Dergi Adı: REDOX REPORT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.107-112
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Objectives: Some studies have indicated the pathophysiological importance of reactive oxygen species (ROS) in patients with nephrotic syndrome. Myeloperoxidase (MPO) is a leukocyte-derived enzyme-generating ROS that has been proposed to exert a wide array of pro-atherogenic effects throughout all stages of the atherosclerotic process. The aim of this study was to investigate the serum malondialdehyde (MDA) levels, MPO and catalase activities in patients with adult nephrotic syndrome.